“PROVING THE EFFICACY OF MANGIFERIN AS A NEUROPROTECTIVE DRUG USING DOCKING STUDIES”, biotech, vol. 3, no. 1, pp. 10–16, Jul. 2018, doi: 10.17501/biotech.2018.3102.